Testing effectiveness (Phase 2)UnknownNCT02648516
What this trial is testing
Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients
Who this might be right for
Human Immunodeficiency VirusDisorder of Immune Reconstitution
Beijing 302 Hospital 20